Stories Tagged as
Pharmaceuticals
Markets come up short in drugs for premature babies
Jul 10, 2013
Nationwide drug shortages are causing hospitals to ration critical nutrients premature babies and other patients need to survive.
How Medicare Part D changed the drug industry
May 22, 2013
The prescription drug plan has created millions of senior customers for the pharmaceutical industry over ten years.
Pfizer wants you to buy Viagra online -- from Pfizer
May 6, 2013
Viagra is one of the most-counterfeited drugs on the web, and Pfizer's latest effort to tackle that issue is a first.
Biogen Idec CEO on drug costs and taking on multiple sclerosis
Apr 11, 2013
Biogen Idec CEO George Scangos discusses his company's new multiple sclerosis drug, pricing strategy, and research process.
India Novartis patent ruling: Good for access, bad for innovation?
Apr 1, 2013
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
India rejects Novartis cancer drug patent
Apr 1, 2013
The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.
Helping drug addicts kick the habit six months at a time
Mar 25, 2013
A new drug, in the final stages of approval by the FDA, could make it easier to give addicts medication without using pills and risking abuse.
For public good, not for profit.
Cheap generic drugs face possible legal liabilities
by
David Gura
Mar 19, 2013
The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drug makers can be held liable for alleged flaws in the designs of their medications.
'Side Effects' tells a tale of medicine, big business and murder
Feb 7, 2013
Stephen Soderbergh's new psychopharmalogical thriller digs into the cozy relationship between doctors and drug companies.
Animal health firm is biggest IPO since Facebook
Feb 1, 2013
Animal health care is the fastest growing sector of health care. Medicine for the pets we love and the livestock we eat is a more than $4 billion business for Zoetis, a company spun off by pharmaceutical giant Pfizer.
Jeff Vanuga/USDA Natural Resources Conservation Service via Getty Images